What is Celldex Therapeutics's capex?

Celldex Therapeutics (CLDX) reported capex of $1.64M in Q1 2026.

How has Celldex Therapeutics's capex changed year-over-year?

Celldex Therapeutics's capex increased by 518.5% year-over-year, from $265K to $1.64M.

What is the long-term trend for Celldex Therapeutics's capex?

Over 4 years (2021 to 2025), Celldex Therapeutics's capex has grown at a 21.4% compound annual growth rate (CAGR), from $1.25M to $2.71M.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Celldex Therapeutics CLDX CapEx

CapEx at other companies

Eli LillyLLY

$2.33B+54.0%

PfizerPFE

$436M-22.7%

Rogers CorporationROG

$4.7M-51.0%

AmgenAMGN

$712M+73.2%

Regeneron PharmaceuticalsREGN

$230.6M+0.6%

IncyteINCY

——

Other financials

Income statement

See full

Revenue$15.0K-97.8%

Operating income-$84.4M-34.6%

Net income-$78.7M-46.3%

EPS (diluted)-$1.18-45.7%

Balance sheet

See full

Cash & equivalents$35.7M+109%

Total debt$1.9M-44.3%

Total equity$456.2M-35.1%

Total assets$511.3M-30.9%

Cash flow

See full

Operating cash flow-$65.6M-20.6%

Free cash flow-$67.2M-23.0%

Valuation

See full

Market cap$2.59B+75.2%

Enterprise value$2.55B+74.4%

P/S2,989.2×+2,794×

Profitability

See full

Operating margin-35,688.5%-39,114pp

Net margin-32,753.6%-35,519pp

FCF margin-26,125.8%-28,907pp

Returns & leverage

See full

Return on equity-48.9%-498pp

Debt / equity0×0.0×

Current ratio8.9×-12.7×

Where this comes from

Reported directly by Celldex Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celldex Therapeutics's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Celldex Therapeutics's capex?: Celldex Therapeutics (CLDX) reported capex of $1.64M in Q1 2026.
How has Celldex Therapeutics's capex changed year-over-year?: Celldex Therapeutics's capex increased by 518.5% year-over-year, from $265K to $1.64M.
What is the long-term trend for Celldex Therapeutics's capex?: Over 4 years (2021 to 2025), Celldex Therapeutics's capex has grown at a 21.4% compound annual growth rate (CAGR), from $1.25M to $2.71M.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.